-
公开(公告)号:EP3914256B1
公开(公告)日:2024-05-29
申请号:EP20745502.3
申请日:2020-01-23
IPC分类号: C07D487/04 , A61K31/60 , C07F5/00
CPC分类号: C07D487/04 , A61P1/00 , C07F5/025
-
公开(公告)号:EP2760433B1
公开(公告)日:2023-05-31
申请号:EP12837423.8
申请日:2012-09-29
IPC分类号: A61K31/192 , A61K9/10 , A61K9/16 , A61K9/14 , A61P1/04 , A61P1/00 , A61K31/196 , A61K31/405 , A61K31/60 , A61K31/616 , A61P29/00
-
公开(公告)号:EP4103173A1
公开(公告)日:2022-12-21
申请号:EP21813389.0
申请日:2021-05-19
申请人: INNOCAN PHARMA LTD.
发明人: AVRAM, Nir
IPC分类号: A61K31/352 , A61K31/203 , A61K31/4166 , A61K31/60 , A61K33/30 , A61K35/04 , A61K9/00 , A61P17/06 , A61P17/08
-
公开(公告)号:EP4052708A1
公开(公告)日:2022-09-07
申请号:EP20883140.4
申请日:2020-10-30
发明人: HIKITA, Chie
摘要: There is provided an agent for suppressing the insulin resistance of a ruminant, the agent including cashew nut shell liquid, heated cashew nut shell liquid, anacardic acid, cardanol, and/or cardol.
-
公开(公告)号:EP3273952B1
公开(公告)日:2022-06-15
申请号:EP16769429.8
申请日:2016-03-18
IPC分类号: A61K31/10 , A61K31/445 , A61K31/473 , A61K31/60 , A61K45/06 , A61K9/00 , A61K31/192 , A61K31/196 , A61K31/407 , A61P1/02 , A61P3/02 , A61P29/00 , A61P39/02 , A61P43/00 , A61K31/4545 , A61K31/495 , A61K31/603
-
公开(公告)号:EP3998066A1
公开(公告)日:2022-05-18
申请号:EP21191811.5
申请日:2016-04-15
发明人: RIEL, Susanne
IPC分类号: A61K31/165 , A61K31/60 , A61P9/00 , A61P29/00 , A61P7/02 , A61P9/10 , A61P19/06 , A61P25/28 , A61P27/02 , A61P29/02 , A61P43/00
摘要: Pharmaceutical compositions of colchicine salicylate, including once-a-day orally administered formulations are provided. Method of treating and/or preventing cardiovascular disease and/or inflammatory disease in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
-
公开(公告)号:EP3475425B1
公开(公告)日:2021-08-25
申请号:EP17732939.8
申请日:2017-06-28
IPC分类号: C12N15/113 , A61K31/60 , A61K31/7088 , A61P1/16
-
公开(公告)号:EP3708152A1
公开(公告)日:2020-09-16
申请号:EP19840552.4
申请日:2019-06-26
发明人: WANG, Guangji
摘要: An azelaic acid gel, and a preparation method and an application thereof. The azelaic acid gel comprises the following components in percentage by weight: azelaic acid: 10-20%; salicylic acid: 0.5-2%; a polyacrylate cross-linked polymer-6: 1-3%; 1,3-propylene glycol: 60-74%; and the remaining part being water. The azelaic acid gel is used for preparing medicines for preventing or treating acnes.
-
公开(公告)号:EP3518864B1
公开(公告)日:2020-08-05
申请号:EP17784075.8
申请日:2017-09-20
发明人: BINNER, Curt , PAUNESCU, Alexandru
-
公开(公告)号:EP3659607A1
公开(公告)日:2020-06-03
申请号:EP19206063.0
申请日:2016-05-04
摘要: Enema compositions containing corticosteroids or salicylic acid derivatives are disclosed. The compositions are liquid at room temperature but turn to gels at body temperature. They are useful for treating inflammatory bowel disease.
-
-
-
-
-
-
-
-
-